Loading patent…
AssigneeBoehringer Ingelheim International GmbH
InventorsAndreas Zophel, Horst Johann Ahorn, Birgit Jung, Renate Konopitzky, Karl-Heinz Heider, Norbert Kraut, Peter Seither, Thomas Waerner, Hartmut Beug, Martin Jechlinger, Ido M. Tamir, Andreas Weith, Stefan Gruenert
Estimating the term…
The functional characterization of ILEI to be a novel cytokine involved in epithelial/mesenchymal transition and the identification of biologically active ILEI provides the basis for generating ILEI inhibitors, in particular anti-ILEI antibodies, that are useful in the therapy of cancer, fibrosis and COPD.
An antibody or an antibody fragment which binds to a polypeptide which consists of the sequence set forth in SEQ ID NO:
An antibody or an antibody fragment which binds to a polypeptide which consists of amino acids 189 to 211 of SEQ ID NO:
Dependencies are inferred from the claim text.